Slim Weight Loss Clinic

Slim Weight Loss Clinic in Woodbury, Minnesota, operates under the medical direction of Dr. Gary T. Marshall, MD, FACS, a board-certified surgeon who applies surgical precision and metabolic expertise to non-surgical weight management. The clinic focuses exclusively on evidence-based pharmacotherapy for obesity and metabolic dysfunction, serving patients throughout the Twin Cities metro area who require structured medical intervention beyond diet and exercise alone. Dr. Marshall's background in bariatric surgery informs his approach to patient selection and medication management, ensuring appropriate candidates receive GLP-1 receptor agonist therapy with proper monitoring and support.

The clinic's treatment protocols center on three FDA-approved GLP-1 receptor agonists: semaglutide, tirzepatide, and liraglutide. Semaglutide is offered for patients seeking once-weekly subcutaneous injection therapy, with dosing titrated from 0.25 mg to maintenance levels based on individual tolerance and response. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is prescribed for patients who may benefit from the additional incretin pathway activation, particularly those with concurrent type 2 diabetes or significant insulin resistance. Liraglutide serves as an alternative for patients requiring daily dosing flexibility or those who have previously used this agent with success. Each medication is selected based on patient-specific factors including BMI, comorbid conditions, insurance coverage, and treatment goals, with Dr. Marshall conducting comprehensive metabolic assessments before initiating therapy.

Dr. Marshall's credentials as a Fellow of the American College of Surgeons (FACS) distinguish his clinical approach from standard weight loss programs. His surgical training provides advanced understanding of metabolic physiology, hormonal regulation of appetite, and the systemic effects of obesity on cardiovascular, hepatic, and musculoskeletal systems. This expertise allows for nuanced patient evaluation, including identification of contraindications, management of side effects such as gastroparesis or gallbladder complications, and coordination with patients' primary care physicians and endocrinologists. The clinic maintains protocols for monitoring liver function, lipid panels, and hemoglobin A1c throughout treatment, adjusting pharmacotherapy as metabolic parameters improve.

Patients at Slim Weight Loss Clinic in Woodbury attend in-person consultations where Dr. Marshall performs initial evaluations including body composition analysis, review of weight history, assessment of previous weight loss attempts, and screening for obesity-related comorbidities. Follow-up appointments occur at regular intervals aligned with medication titration schedules—typically every four weeks during dose escalation, then every eight to twelve weeks during maintenance phases. The clinic provides injection technique training for patients self-administering semaglutide or tirzepatide, along with written protocols for managing common side effects like nausea, constipation, or injection site reactions. Nutritional guidance emphasizes protein intake preservation and micronutrient supplementation to prevent deficiencies during rapid weight reduction phases.

The clinic's Woodbury location on Valley Creek Road provides accessible care for residents of Washington County and eastern Twin Cities suburbs, with appointment availability designed to accommodate working professionals. Slim Weight Loss Clinic does not offer telehealth services, reflecting Dr. Marshall's clinical philosophy that obesity pharmacotherapy requires hands-on medical assessment, particularly for monitoring cardiovascular parameters and detecting early signs of medication complications. This in-person model allows for real-time problem-solving when patients experience dose-limiting side effects or weight loss plateaus, with same-visit medication adjustments when clinically appropriate. The practice accepts most major insurance plans for office visits, though patients should verify coverage for GLP-1 medications specifically, as formulary status varies significantly among carriers and often requires prior authorization documentation that the clinic assists in preparing.